Technical Analysis for AGIO - Agios Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 48.33 -1.55% -0.76
AGIO closed down 1.55 percent on Friday, May 24, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AGIO trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -1.55%
Multiple of Ten Bearish Other -1.55%
20 DMA Resistance Bearish -5.88%
Spinning Top Other -5.88%
Calm After Storm Range Contraction -5.88%
MACD Bullish Signal Line Cross Bullish -5.90%
Multiple of Ten Bullish Other -5.90%

Older signals for AGIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its products include AG-221, an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations; and enzyme glutaminase that converts the nutrient glutamine into the metabolite glutamate. The company's products also comprise AG-348, an oral small molecule activator of PKR enzyme for the treatment of patients with pyruvate kinase deficiency. It has a collaboration agreement with Celgene Corporation. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Chemistry Biopharmaceutical Cancer Cancers Organic Chemistry Inborn Errors Of Metabolism Agios Pharmaceuticals
Is AGIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 99.82
52 Week Low 41.63
Average Volume 514,604
200-Day Moving Average 62.2697
50-Day Moving Average 58.0152
20-Day Moving Average 50.993
10-Day Moving Average 49.045
Average True Range 2.767
ADX 34.89
+DI 16.9036
-DI 26.4481
Chandelier Exit (Long, 3 ATRs ) 49.809
Chandelier Exit (Short, 3 ATRs ) 54.611
Upper Bollinger Band 56.5354
Lower Bollinger Band 45.4506
Percent B (%b) 0.26
BandWidth 21.737886
MACD Line -2.4214
MACD Signal Line -2.7312
MACD Histogram 0.3098
Fundamentals Value
Market Cap 2.34 Billion
Num Shares 48.4 Million
EPS -6.33
Price-to-Earnings (P/E) Ratio -7.64
Price-to-Sales 59.19
Price-to-Book 6.21
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.02
Resistance 3 (R3) 52.33 51.42 51.41
Resistance 2 (R2) 51.42 50.48 51.26 51.20
Resistance 1 (R1) 49.87 49.90 49.42 49.56 50.99
Pivot Point 48.96 48.96 48.73 48.80 48.96
Support 1 (S1) 47.41 48.02 46.96 47.10 45.67
Support 2 (S2) 46.50 47.44 46.34 45.46
Support 3 (S3) 44.95 46.50 45.26
Support 4 (S4) 44.64